REVERSES ALCOHOL-INDUCED HEPATIC STEATOSIS
December 21, 2023POTENT ANTIHYPERTENSIVE
December 21, 2023
- Improved arterial compliance by a novel advanced glycation end-product crosslink breaker
- Role of the AGE crosslink breaker, alagebrium, as a renoprotective agent in diabetes
- Advanced glycation endproduct crosslink breaker (alagebrium) improves endothelial function in patients with isolated systolic hypertension
- The effect of an advanced glycation end-product crosslink breaker and exercise training on vascular function in older individuals: a randomized factorial design trial
- Reversal of chaperone activity loss of glycated αA-crystallin by a crosslink breaker
- Reversal Of Lens Protein Crosslinking And Aggregation By A Novel crosslink breaker
- The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure
- A breaker of advanced glycation end products attenuates diabetes-induced myocardial structural changes
- The Effect of the AGE crosslink breaker ALT-711 on Accommodation, Outflow Facility, IOP, and Anterior Segment Morphology
- Advanced Glycation Endproduct “AGE” Accumulation in Elderly Hypertensive Canines: Correlation with Effects of AGE crosslink breaker
- The thiamine analogue and advanced glycation endproducts crosslink breaker ALT-711 does not interfere with transketolase activity
- Effects of alagebrium, an advanced glycation end‐product breaker, in patients with chronic heart failure: study design and baseline characteristics of the BENEFICIAL …
- An agent cleaving glucose-derived protein crosslinks in vitro and in vivo
- Effects of alagebrium, an advanced glycation endproduct breaker, on exercise tolerance and cardiac function in patients with chronic heart failure
- Therapeutic potential of breakers of advanced glycation end product–protein crosslinks
- Evaluation in vitro of AGE-crosslinks breaking ability of rosmarinic acid
- Advanced glycation end-products (AGEs): a novel therapeutic target for osteoporosis in patients with rheumatoid arthritis
- … and clinical improvements among patients with advanced heart failure treated with Alagebrium (a novel oral advanced glycation end-product crosslink breaker)
- Current therapeutic interventions in the glycation pathway: evidence from clinical studies
- The Effect of Advanced Glycation End Products (AGE) breaker, Alagebrium on the Cardiac Structural and Functional Change in Type I Diabetic Rat Model
- Evaluate the effect of Withania somnifera methanolic extracts as in-vitro antiglycating agents
- C16, a novel advanced glycation endproduct breaker, restores cardiovascular dysfunction in experimental diabetic rats1
- The breakdown of pre‐existing advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes
- Effects of Advanced Glycation End-Product Inhibition and Protein Cross-Link Breaking in Diabetic Rats
- The putative antiglycation agent phenacylthiazolium bromide suppresses cellular triosephosphate accumulation in model hyperglycaemia in vitro by stimulating the …
- Alagebrium attenuates methylglyoxal induced oxidative stress and AGE formation in H9C2 cardiac myocytes
- Pharmacological therapy of age-related macular degeneration based on etiopathogenesis
- Effect of the AGE-breaker alagebrium on plasma and tissue advanced glycation end-products and sRAGE
- Extracellular glycation crosslinks: prospects for removal
- Factors influencing crosslink formation in muscle tissue
- Effect of advanced glycation end‐products (AGE) lowering drug ALT‐711 on biochemical, vascular, and bone parameters in a rat model of CKD‐MBD
- Advanced glycation endproduct crosslinking in the cardiovascular system: potential therapeutic target for cardiovascular disease
- Effects of alagebrium, an AGE breaker, on exercise tolerance and cardiac function in patients with chronic heart failure
- Effect of non-antihypertensive drugs on endothelial function in hypertensive subjects evaluated by flow-mediated vasodilation
- Treating diastolic heart failure with AGE crosslink breakers: thinking outside the heart failure box
- Novel therapies for diabetic kidney disease: storied past and forward paths
- Aldose reductase inhibition ameliorates the detrimental effect of estrogen replacement therapy on neuropathology in diabetic rats subjected to transient forebrain …
- Novel in Vitro Modification of Bone for an Allograft with Improved Toughness Osteoconductivity
- Gut microbiome-derived metabolite trimethylamine N-oxide induces aortic stiffening and increases systolic blood pressure with aging in mice and humans
- Effect of cysteine on methylglyoxal-induced renal damage in mesangial cells
- Advanced glycation endproduct induces ROS accumulation, apoptosis, MAP kinase activation and nuclear O-GlcNAcylation in human cardiac myocytes
- Cardiovascular Complications
- Staphylococcus aureus Biofilm Inhibiting Activity of Advanced Glycation Endproduct crosslink Breaking and Glycation Inhibiting Compounds
- crosslink breakers: a new approach to cardiovascular therapy
- Alagebrium: benefit on peripheral arteries
- Advanced glycation end-products in chronic heart failure
- The effect of advanced glycation end products (AGE) breaker, alagebrium on the cardiac structural and functional change in type I diabetic rat model
- Phenotypic transitions and fibrosis in diabetic nephropathy
- Heart-Kidney Connection: Myocardial Infarction Induces Renal Cortical and Medullary Fibrosis and Activation of Renal Molecular Remodeling in the Absence of Heart …
- Effect of the age cross-link breaker alagebrium on anterior segment physiology, morphology, and ocular age and rage
- Diversity in management of heart failure patients
- Uncoupled Nitric Oxide Synthase Leads to Diastolic Dysfunction Irrespective of Blood Pressure
- The Effect of Breaking Advanced Glycation End-Products, With or Without Exercise Training on the Cardiovascular Effects of Aging
- Skin autofluorescence, 5-year mortality, and cardiovascular events in peripheral arterial disease: all that glitters is surely not gold
- Getting better without AGE: new insights into the diabetic heart
- The role of collagen crosslinks in ageing and diabetes-the good, the bad, and the ugly
- Vascular aging: from molecular mechanism to clinical significance
- Cleaving effect of pomegranate (Punica granatum) extract on crosslink derived from advanced glycation endproducts
- Alagebrium in combination with exercise ameliorates age-associated ventricular and vascular stiffness
- Pyridoxal phosphate prevents progression of diabetic nephropathy
- The AGE of the matrix: chemistry, consequence and cure
- Dyssynchrony in Regional Left Ventricular Systolic Function in Light Chain Amyloidosis: Assessment Using Novel 4D Echocardiography
- Inhibitors of the Maillard reaction and AGE breakers as therapeutics for multiple diseases
- Cardiovascular and renal effects of a collagen cross-link breaker (ALT 711) in adult and aged spontaneously hypertensive rats
- Hyperglycemia and arterial stiffness: the atherosclerosis risk in the communities study
- Fracturing Carbonate Reservoirs: Acidising Fracturing or Fracturing with Proppants?
- Alagebrium chloride protects the heart against oxidative stress in aging rats
- The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy
- Arterial stiffness: a focus on vascular calcification and its link to bone mineralization
- Advanced glycation end products, oxidative stress and diabetic nephropathy
- Diabetic nephropathy: important pathophysiologic mechanisms
- Advanced glycation end products in health and disease
- EFFECT OF AGE ON SHEAR MODULUS OF SKELTAL MUSCLE
- A review on prevention of glycation of proteins: Potential therapeutic substances to mitigate the severity of diabetes complications
- Targeting advanced glycation with pharmaceutical agents: where are we now?
- Inhibition of renin-angiotensin system and advanced glycation end products formation: a promising therapeutic approach targeting on cardiovascular diseases
- Therapeutic interventions for advanced glycation-end products and its receptor-mediated cardiovascular disease
- The inhibition of advanced glycation end products by carnosine and other natural dipeptides to reduce diabetic and age‐related complications
- The role of AGE/RAGE signaling in diabetes-mediated vascular calcification
- AGE-breaker ALT-711 plus insulin could restore erectile function in streptozocin-induced type 1 diabetic rats
- Advanced glycation/glycoxidation endproduct carboxymethyl-lysine and incidence of coronary heart disease and stroke in older adults
- Assessing the potential of carboxylic acids as inhibitors of glycation
- N-phenacylthiazolium bromide reduces bone fragility induced by nonenzymatic glycation
- Repairing extracellular aging and glycation
- Potential new therapeutic agents for diabetic kidney disease
- Serum carboxymethyl–lysine, an advanced glycation end product, is associated with increased aortic pulse wave velocity in adults
- Diabetes and advanced glycation endproducts
- Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart
- Causes and characteristics of diabetic cardiomyopathy
- Advanced glycation and retinal pathology during diabetes
- AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept
- Pimagedine: a novel therapy for diabetic nephropathy
- Blockade of diabetic vascular injury by controlling of AGE-RAGE system
- Advanced glycation end-product cross-link breakers: a novel approach to cardiovascular pathologies related to the aging process
- Alagebrium (ALT-711) Attenuates Gastric Aspiration Induced Pulmonary Inflammatory Response In Mice Fed With High AGE Diet
- The putative role of methylglyoxal in arterial stiffening: A review
- Receptor for advanced glycation end products (RAGE): novel biomarker and therapeutic target for atrial fibrillation
- The effects of advanced glycation end products (AGEs) on dermal wound healing and scar formation: a systematic review
- Advanced glycation end-products and arterial stiffness in hypertension
- Role of AGEs in diabetic nephropathy
- TRC4186, a novel AGE-breaker, improves diabetic cardiomyopathy and nephropathy in Ob-ZSF1 model of type 2 diabetes
- The breakdown of preformed advanced glycation end products reverses erectile dysfunction in streptozotocin‐induced diabetic rats: Preventive versus curative …
- Therapeutic potential of AGE inhibitors and breakers of AGE protein cross-links
- Advanced glycation end products in renal failure: an overview
- Causative or associative: A critical review of the role of advanced glycation end-products in bone fragility
- Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus
- Advanced glycation end products and diabetic complications
- Hydralazine inhibits rapid acrolein-induced protein oligomerization: role of aldehyde scavenging and adduct trapping in cross-link blocking and cytoprotection
- Republished paper: arterial stiffness in chronic kidney disease: causes and consequences
- The multiple faces of RAGE–opportunities for therapeutic intervention in aging and chronic disease
- Large artery stiffness and brain health: Insights from animal models
- Effect of Korean red ginseng on arterial stiffness in subjects with hypertension
- Therapeutic interventions in the glyc (oxid) ation pathway
- Novel therapeutics for diabetic micro-and macrovascular complications
- Heart failure with preserved ejection fraction: emerging drug strategies
- Effect of Cirsium japonicum Flower Extract on Skin Aging Induced by Glycation
- Advanced glycation of apolipoprotein AI impairs its anti-atherogenic properties
- The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction
- Study on the nonenzymatic glycation of nucleosides/nucleotides and proteins with sugars: An in vitro investigation of advanced glycation endproducts (AGEs) …
- AGEs impair Kv channel-mediated vasodilation of coronary arteries by activating the NF-κB signaling pathway in ZDF rats
- Protein glycation during aging and in cardiovascular disease
- Methylglyoxal impairs glucose metabolism and leads to energy depletion in neuronal cells—protection by carbonyl scavengers
- The role of collagen metabolism in CKD-associated arterial senescence: underestimated and underappreciated
- Protein crosslinking by the maillard reaction with ascorbic acid and glucose
- Advanced glycation endproducts and plaque instability: a link beyond diabetes
- An update on advanced glycation endproducts and atherosclerosis
- Skin autofluorescence, a marker for advanced glycation end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease
- Advanced glycation endproducts (AGEs): pharmacological inhibition in diabetes
- Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis
- AGEs and cardiovascular diseases in patients with end-stage renal diseases
- Targeting advanced glycation endproducts and mitochondrial dysfunction in cardiovascular disease
- Glucose, Glycation, and RAGE: Implications for Amplification of Cellular Dysfunction in Diabetic Nephropath: y
- The role of advanced glycation in the pathogenesis of diabetic retinopathy
- Does accumulation of advanced glycation end products contribute to the aging phenotype?
- Potential clinical utility of advanced glycation end product cross-link breakers in age-and diabetes-associated disorders
- Emerging therapies for chronic kidney disease: what is their role?
- Effects of alagebrium, an AGE breaker, in patients with chronic heart failure: study design and baseline characteristics of the BENEFICIAL trial
- Low adipocyte IRS-1 protein expression is associated with an increased arterial stiffness in non-diabetic males
- Advanced glycation end products and schizophrenia: A systematic review
- Pharmacological control of receptor of advanced glycation end-products and its biological effects in psoriasis
- Physical properties of anionic poly (ε-caprolactam) synthesized in the presence of calcium chloride
- AGE-RAGE axis blockade in diabetic nephropathy: current status and future directions
- Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients
- Collagen cross-link breakers: a beginning of a new era in the treatment of cardiovascular changes associated with aging, diabetes, and hypertension
- Advanced glycation end products and their circulating receptors and level of kidney function in older community-dwelling women
- Methylglyoxal and advanced glycation endproducts: new therapeutic horizons?
- Functional effects of alagebrium (alt-711)–isolated rat carotid artery
- The advanced glycation end product-lowering agent ALT-711 is a low-affinity inhibitor of thiamine diphosphokinase
- Advanced glycation: an important pathological event in diabetic and age related ocular disease
- Role of advanced glycation end products in hypertension and atherosclerosis: therapeutic implications
- Oxidative stress and aging: is methylglyoxal the hidden enemy?
- Phase I clinical studies of the advanced glycation end-product (AGE)-breaker TRC4186: safety, tolerability and pharmacokinetics in healthy subjects
- Regulation of advanced glycation end product (AGE)-receptor (RAGE) system by PPAR-gamma agonists and its implication in cardiovascular disease
- Multi-User Publishing in the Web: DReSS, A Document Repository Service Station
- Current perspectives in diastolic dysfunction and diastolic heart failure
- Methylglyoxal displays colorectal cancer-promoting properties in the murine models of azoxymethane and CT26 isografts
- Aldose reductase pathway inhibition improved vascular and C-fiber functions, allowing for pressure-induced vasodilation restoration during severe diabetic …
- Modulation of α‐crystallin chaperone activity: A target to prevent or delay cataract?
- Impaired left ventricular relaxation in type 2 diabetic rats is related to myocardial accumulation of Nɛ‐(carboxymethyl) lysine
- Optimal treatment of hypertension with diastolic heart failure
- Agents in development for the treatment of diabetic nephropathy
- How important and how treatable is vascular stiffness as a cardiovascular risk factor in renal failure?
- Nephrin loss in experimental diabetic nephropathy is prevented by deletion of protein kinase C alpha signaling in-vivo
- Alagebrium and complications of diabetes mellitus
- Advanced glycation endproducts and osteoarthritis
- Role of advanced glycation end products in diabetic neuropathy
- Do diabetes and hypertension interact to accelerate vascular ageing?
- Drug therapy for the cardiac complications of diabetes
- Vascular mechanics in decellularized aortas and coronary resistance microvessels in type 2 diabetic db/db mice
- Molecular determinants of heart failure with normal left ventricular ejection fraction
- Effects of cross-link breakers, glycation inhibitors and insulin sensitisers on HDL function and the non-enzymatic glycation of apolipoprotein AI
- Quinapril treatment abolishes diabetes-associated atherosclerosis in RAGE/apolipoprotein E double knockout mice
- Impact of age and hyperglycemia on the mechanical behavior of intact human coronary arteries: an ex vivo intravascular ultrasound study
- Preferential stiffening of central over peripheral arteries in type 2 diabetes
- A short-term admission improved brachial–ankle pulse wave velocity in type 2 diabetic patients
- New drugs under development for cardiovascular prevention
- The breakdown of preformed peritoneal advanced glycation end products by intraperitoneal alagebrium
- Arterial stiffness and wave reflections in relation to plasma advanced glycation end products in a Chinese population
- Cellular mechanisms and consequences of glycation in atherosclerosis and obesity
- Karl D. Nolph state of the art lecture: feasible and future options for salvation of the peritoneal membrane
- Heart Failure with Preserved Ejection Fraction
- Glycation: Receptor for Advanced Glycation Endproducts and Diabetic Nephropathy
- Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines
- Arterial stiffening: Causes and consequences
- Heart failure and diabetes mellitus: epidemiology and management of an alarming association
- Discovery of Anti-Glycation and AGEs breaker Agents and Study of their Mechanism of Action
- Jakyakgamcho-tang and its major component, Paeonia lactiflora, exhibit potent anti-glycation properties
- Clinical trials update from the European Society of Cardiology Heart Failure Meeting 2010: TRIDENT 1, BENEFICIAL, CUPID, RFA‐HF, MUSIC, DUEL, handheld BNP …
- Alteration of pressure-induced vasodilation in aging and diabetes, a neuro-vascular damage
- Targeting matrix remodeling in cardiac hypertrophy and heart failure
- The role of advanced glycation end products in retinal ageing and disease
- Targeting AGEs signaling ameliorates central nervous system diabetic complications in rats
- Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study
- Neurodegenerative diseases of the retina and potential for protection and recovery
- New drugs, procedures, and devices for hypertension
- Location of arterial stiffening differs in those with impaired fasting glucose versus diabetes: implications for left ventricular hypertrophy from the Multi-Ethnic Study of …
- Mechanisms of arterial remodeling: lessons from genetic diseases
- The accumulation of the glycoxidation product Nε-carboxymethyllysine in Cardiac Tissues with age, diabetes mellitus and coronary heart disease
- The effects of antihypertensive drugs on arterial stiffness
- Diabetic neuropathy is closely associated with arterial stiffening and thickness in type 2 diabetes
- Targeted reduction of advanced glycation improves renal function in obesity
- To AGE or not to age. The effect of physical activity and advanced glycation end-products (AGEs) on the vasculature in older individuals
- Characteristics, formation, and pathophysiology of glucosepane: a major protein cross-link
- Advanced glycation end‐products induce skeletal muscle atrophy and dysfunction in diabetic mice via a RAGE‐mediated, AMPK‐down‐regulated, Akt pathway
- Molecular mechanisms of diabetic cardiomyopathy
- Glycation: Implication in perceived age and dermatology
- Type-I Angiotensin II Receptor Blockade Reduces Uremia-induced Deterioration of Bone Material
- (−)-Epicatechin Ameliorates Cardiac Fibrosis in a Female Rat Model of Pre-Heart Failure with Preserved Ejection Fraction
- Advanced glycation and advanced lipoxidation: possible role in initiation and progression of diabetic retinopathy
- Protective effect of vanillin on diabetic nephropathy by decreasing advanced glycation end products in rats
- Compounds that combine aldose reductase inhibitory activity and ability to prevent the glycation (glucation and/or fructation) of proteins as putative …
- Alagebrium chloride, a novel AGE cross linkage breaker, inhibits neointimal proliferation after carotid balloon injury in diabetic animal model
- Cardiovascular prevention: relationships between arterial aging and chronic drug treatment
- Therapeutic options to reduce advanced glycation end products in patients with diabetes mellitus: A review
- Pathophysiology of diabetic retinopathy
- Heart failure: novel therapeutic approaches
- Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms
- Diabetic cardiomyopathy: do women differ from men?
- Clinic and ambulatory blood pressure in relation to the interaction between plasma advanced glycation end products and sodium dietary intake and renal handling
- Response to “A Short Insight on Two Different Aspects of Arterial Stiffness”; Moving Forward or Backward?
- Renoprotective antioxidant effect of alagebrium in experimental diabetes
- Arterial stiffness and hand osteoarthritis: a novel relationship?
- Plasma advanced glycation end products (AGEs) and NF-κB activity are independent determinants of diastolic and pulse pressure
- Heart failure with normal ejection fraction
- Contractile dysfunction in hypertrophied hearts with deficient insulin receptor signaling: possible role of reduced capillary density
- The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease
- Linking RAGE and Nox in diabetic micro-and macrovascular complications
- The next generation of diabetic nephropathy therapies: an update
- Epicatechin breaks preformed glycated serum albumin and reverses the retinal accumulation of advanced glycation end products
- RAGE and cardiovascular disease
- Vieillissement: rôle et contrôle de la glycation
- Therapeutic potential of α-crystallin
- The role of advanced glycation end products in the development of atherosclerosis
- Senescence mediated redox imbalance in cardiac tissue: Antioxidant rejuvenating potential of green tea extract
- Effects of body mass index, plasma glucose and cholesterol levels on isolated systolic hypertension
- Collagen crosslinking: effect on structure, mechanics and fibrosis progression
- Arterial stiffness and arterial wave reflections are associated with systolic and diastolic function in patients with normal ejection fraction
- Influence of lifestyle modification on arterial stiffness and wave reflections
- The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007
- Aging and ocular tissue stiffness in glaucoma
- Emerging role of advanced glycation-end products (AGEs) in the pathobiology of eye diseases
- The role of advanced glycation end products on sarcoplasmic reticulum calcium handling during diabetic cardiomyopathy
- Tiny molecule, big power: multi-target approach for curcumin in diabetic cardiomyopathy
- Higher levels of advanced glycation endproducts in human carotid atherosclerotic plaques are associated with a rupture-prone phenotype
- Microvascular degenerative complications are associated with increased aortic stiffness in type 2 diabetic patients
- Arterial stiffness in renal patients: an update
- Structural proteins and arterial ageing
- The role of AGEs in cardiovascular disease
- Agents that block advanced glycation end product (AGE)-RAGE (receptor for AGEs)-oxidative stress system: a novel therapeutic strategy for diabetic vascular …
- Pharmacologic approaches against advanced glycation end products (AGEs) in diabetic cardiovascular disease
- Vascular compliance in hypertension: therapeutic implications
- Mechanistic targeting of advanced glycation end-products in age-related diseases
- Advanced glycation end products (AGEs), receptor for AGEs, diabetes, and bone: review of the literature
- Therapeutic interventions against accumulation of advanced glycation end products (AGEs)
- Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and cardiomyocyte stiffness
- Renal accumulation and clearance of advanced glycation end-products in type 2 diabetic nephropathy: effect of angiotensin-converting enzyme and …
- Emerging drugs for acute and chronic heart failure: current and future developments
- Skin autofluorescence corresponds to microvascular reactivity in diabetes mellitus
- Mutational Studies of the Receptor for Advanced Glycation End Products (RAGE) Inhibition
- Pharmacological evaluation of novel alagebrium analogs as methylglyoxal scavengers in vitro in cardiac myocytes and in vivo in SD rats
- Effect of ageing on left ventricular compliance and distensibility in healthy sedentary humans
- Emerging concepts in cardiac matrix biology
- Model studies of advanced glycation end product modification of heterograft biomaterials: The effects of in vitro glucose, glyoxal, and serum albumin on collagen …
- Novel therapeutic targets for diabetic nephropathy
- Glycative stress and anti-aging: 14. Regulation of Glycative stress. 2. Inhibition of the AGE production and accumulation
- Cytotoxicity of advanced glycation endproducts in human micro-and astroglial cell lines depends on the degree of protein glycation
- Alagebrium (ALT-711) improves the anti-hypertensive efficacy of nifedipine in diabetic-hypertensive rats
- Large elastic artery stiffness with aging: novel translational mechanisms and interventions
- Research Article Targeting AGEs Signaling Ameliorates Central Nervous System Diabetic Complications in Rats
- A comparison of dicarbonyl stress and advanced glycation endproducts in lifelong endurance athletes vs. sedentary controls
- Advanced glycation end-products as a potential target for treatment of cardiovascular disease
- ASSOCIATION FOR ACADEMIC SURGERY AND SOCIETY OF UNIVERSITY SURGEONS—ABSTRACTS 260
- Cardiac fibrosis and aging
- Metabolic parameters associated with arterial stiffness in older adults with Type 2 diabetes: the Edinburgh Type 2 diabetes study
- Advanced glycation end products and cardiovascular disease
- In vitro and in vivo antiglycation effects of connarus ruber extract
- Arterial stiffness in predialysis patients with uremia
- ADVANCED GLYCATED END PRODUCTS: A REVIEW
- Longitudinal changes in vascular risk markers and mortality rates among a Latino population with hypertension
- The axis AGE-RAGE-soluble RAGE and oxidative stress in chronic kidney disease
- Molecular mechanisms associated with diabetic endothelial–erectile dysfunction
- Advanced glycation end product (AGE) accumulation in the skin is associated with depression: the Maastricht study
- Functional and Hemodynam ic Cardiac Determinants of Exercise Capacity in Patients with Systolic Heart Failure
- Advanced glycation end-products in cardiac and renal failure
- Arterial stiffness and stroke: de-stiffening strategy, a therapeutic target for stroke
- Agents in development for the treatment of diabetic nephropathy
- The AGE–RAGE pathway and its relation to cardiovascular disease in patients with chronic kidney disease
- Clinical applications of arterial stiffness: therapeutics and pharmacology
- Future treatment of hypertension: shifting the focus from blood pressure lowering to arterial stiffness modulation?
- Of mice and men: models and mechanisms of diabetic cardiomyopathy
- What are new avenues for renal protection, in addition to RAAS inhibition?
- Medical treatment of Marfan syndrome: a time for change
- Therapeutic modification of arterial stiffness: An update and comprehensive review
- The possible role of advanced glycation endproducts (AGEs) in experimentally-induced ischemic brain damage.
- Age-related intimal stiffening enhances endothelial permeability and leukocyte transmigration
- Slowing arterial aging: how far have we progressed?
- Obesity and vascular compliance
- Arterial stiffness, vascular calcification and bone metabolism in chronic kidney disease
- Skin autofluorescence is increased in systemic lupus erythematosus but is not reflected by elevated plasma levels of advanced glycation endproducts
- Intraoperative sRAGE-Kinetik: Ein neuer altersbezogener Outcome-Prädiktor der kardialen Chirurgie
- Alpha-dicarbonyl stress: implications for obesity and type 2 diabetes?
- Central arterial aging and the epidemic of systolic hypertension and atherosclerosis
- Advanced glycation end-products, measured as skin autofluorescence, associate with vascular stiffness in diabetic, pre-diabetic and normoglycemic …
- Ageing and vascular ageing
- Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes
- The bencfit-to-risk ratio of common treatments in PCOS: effect of oral contraceptives versus metformin on atherogenic markers
- Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications
- RAGE in the pathophysiology of skeletal muscle
- Differential effects of glyoxalase 1 overexpression on diabetic atherosclerosis and renal dysfunction in streptozotocin‐treated, apolipoprotein E‐deficient mice
- Corneal stiffness and collagen cross-linking proteins in glaucoma: Potential for novel therapeutic strategy
- Why don’t fistulas mature?
- New insights into the causes of heart failure
- Receptor for advanced glycation endproducts and atherosclerosis: from basic mechanisms to clinical implications
- 5. Crucial involvement of advanced glycation end-products in experimental diabetes-associated arterial elastocalcinosis.
- The future of aging therapies
- Soluble receptor for advanced glycation end products and increased aortic stiffness in the general population
- Influence of RAGE Signaling on Cellular Communication in Diabetes-Mediated Vascular Calcification
- Current concepts in the management of diabetic nephropathy
- Prognostic impact of aortic stiffness in high-risk type 2 diabetic patients: the Rio de Janeiro Type 2 Diabetes Cohort Study
- Role of advanced glycation end products in cardiovascular disease
- Diabetic Kidney Disease: From Pathogenesis to Novel Treatment Possibilities
- The metabolic syndrome in elderly individuals is associated with greater muscular, but not elastic arterial stiffness, independent of low-grade inflammation, endothelial …
- Lifelong cyclic mechanical strain promotes large elastic artery stiffening: increased pulse pressure and old age-related organ failure
- Arterial blood pressure and stiffness in hypertension: is arterial structure important?
- Erectile dysfunction in the elderly: epidemiology, etiology and approaches to treatment
- Physical activity and markers of glycation in older individuals: data from a combined cross-sectional and randomized controlled trial (EXAMIN age)
- Challenging but essential targets for genuine anti-ageing drugs
- Ventricular arterial stiffening: integrating the pathophysiology
- Diabetic cardiomyopathy: signaling defects and therapeutic approaches
- Inhibition of NA+/H+ Exchanger 1 Attenuates Renal Dysfunction Induced by Advanced Glycation End Products in Rats
- Blood pressure, large arteries and atherosclerosis
- Elevated serum advanced glycation end products and their circulating receptors are associated with anaemia in older community-dwelling women
- Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria
- Vascular Stiffness
- Induction and rescue of skeletal fragility in a high-fat diet mouse model of type 2 diabetes: An in vivo and in vitro approach
- Nutrition, Diet, and Supplements for Peak Physical & Mental Performance
- Measurement of arterial stiffness: a novel tool of risk stratification in hypertension
- Receptor for Advanced Glycation End Product, Organ Crosstalk, and Pathomechanism Targets for Comprehensive Molecular Therapeutics in Diabetic Ischemic Stroke
- Alagebrium and spironolactone ameliorate dietary induced metabolic syndrome in male Wister rats
- Advanced glycation endproducts: a biomarker for age as an outcome predictor after cardiac surgery?
- Lens aging: effects of crystallins
- Secondary metabolites from lichen as potent inhibitors of advanced glycation end products and vasodilative agents
- Point of NO return for nitrergic nerves in diabetes: a new insight into diabetic complications
- Diabetic hyperglycemia promotes primary tumor progression through glycation-induced tumor extracellular matrix stiffening
- The Role of Cortical and Cancellous Bone Quality on Vertebral Fragility
- Alagebrium and Spironolactone Ameliorate Dietary Induced Metabolic Syndrome in Male Wister Rats
- Aging and glycoxidant stress
- Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities
- Advanced glycation end products and vascular structure and function
- Nondiabetic glucometabolic status and progression of aortic stiffness: the Whitehall II Study
- Uncertainty quantification and sensitivity analysis of an arterial wall mechanics model for evaluation of vascular drug therapies
- Extracellular Matrix Viscoelasticity Drives Liver Cancer Progression in Pre-Cirrhotic NASH
- Below the Radar: Advanced Glycation End Products that Detour “around the side”: Is HbA1c not an accurate enough predictor of long term progression and …
- Accumulation of advanced glycation end products and chronic complications in ESRD treated by dialysis
- Drug discovery for heart failure: a new era or the end of the pipeline?
- Alterations in myofilament calcium sensitivity and calcium regulation in type 2 diabetic rat heart
- Using myocardial imaging to identify and manage subclinical heart disease in diabetes mellitus and obesity
- Future Therapies in Diastolic Heart Failure
- Avenues for post-translational protein modification prevention and therapy
- Chemical Approaches to Modulate Biological Processes: Unique Activity of N-Phenacylthiazolium Compounds, Bacterial Cell Wall Engineering and Other …
- Therapeutic agents targeting at AGE-RAGE axis for the treatment of diabetes and cardiovascular disease: a review of clinical evidence
- Zagazig University Medical Journa l
- Different impact of hemodialysis vintage on cause-specific mortality in long-term hemodialysis patients
- Advanced glycation end products: sparking the development of diabetic vascular injury
- Deterioration of Glutaraldehyde crosslinked Heterograft Biomaterials due to Advanced Glycation End Product Formation and Serum Albumin Infiltration
- Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation …
- Relation of aortic distensibility determined by magnetic resonance imaging in patients≥ 60 years of age to systolic heart failure and exercise capacity
- Arterial compliance in the elderly: its effect on blood pressure measurement and cardiovascular outcomes
- Cardiac Fibrosis and Aging
- Large arteries and the kidney
- Hypertension, diabetes type II, and their association: role of arterial stiffness
- Obesity in a model of gpx4 haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy
- The diabetic cardiomyopathy: the contributing pathophysiological mechanisms
- Methylglyoxal-induced increase in peroxynitrite and inflammation related to diabetes
- Annual update 2004/2005-Treatment of cardiovascular disorders
- Extracellular matrix changes and vascular smooth muscle signaling
- Mechanical factors in arterial aging: a clinical perspective
- Novel therapies for diabetic kidney disease
- Advanced glycation end-products: implications for diabetic and non-diabetic nephropathies
- Novel therapeutic strategies for reducing arterial stiffness
- Heart failure with preserved ejection fraction: an ongoing enigma
- AGE–RAGE stress, stressors, and antistressors in health and disease
- 5 Diabetes and Advanced
- Decreasing arterial aging by controlling blood pressure levels and hypertension: a step forward
- Pacing and Diastolic Heart Failure
- Role of advanced glycation end products (AGEs) and its receptor (RAGE)-mediated diabetic vascular complications
- Free radicals in aging: causal complexity and its biomedical implications
- Cardiovascular Complications in Renal Failure: Implications of Advanced Glycation End Products and Their Receptor RAGE
- RAGE signaling in inflammation and arterial aging
- Effect of Nebivolol and Lifestyle Modification on Large Artery Stiffness in Middle-Aged and Older Hypertensive Adults
- Receptor for advanced glycation end products and the cardiovascular complications of diabetes and beyond: lessons from AGEing
- Vascular Stiffening Regulates Endothelial Permeability And Smooth Muscle Cell Motility
- Prevention and reversal of diabetic nephropathy in db/db mice treated with alagebrium (ALT-711)
- Advanced glycation end product associated skin autofluorescence: a mirror of vascular function?
- SENS Foundation: Accelerating Progress Toward Biomedical Rejuvenation
- Benefit of glyceryl trinitrate on arterial stiffness is directly due to effects on peripheral arteries
- The AGE-RAGE axis: implications for age-associated arterial diseases
- Combined immunoelectron microscopic and computer-assisted image analyses to detect advanced glycation end-products in human myocardium
- How to treat arterial stiffness beyond blood pressure lowering?
- Pregnancy and Hypertension
- Diabetes and advanced glycoxidation end products
- Central blood pressure and hypertension: role in cardiovascular risk assessment
- Emerging drugs for diabetic nephropathy
- Mechanisms of vascular aging: new perspectives
- Vascular Endothelial Growth Factor as a Determinant of Diabetic Nephropathy
- Early-and advanced non-enzymatic glycation in diabetic vascular complications: the search for therapeutics
- Journal of Pharmaceutical and Scientific Innovation
- Sodium nitrite de-stiffening of large elastic arteries with aging: role of normalization of advanced glycation end-products
- Relationship of advanced glycation end products with cardiovascular disease in menopausal women
- Carotid artery stiffness and diastolic function in subjects without known cardiovascular disease
- Association between systemic arterial stiffness and age-related macular degeneration
- Age-related vascular stiffening: causes and consequences
- Nitrite-induced cross-linking alters remodeling and mechanical properties of collagenous engineered tissues
- Glycation, carbonyl stress and AGEs inhibitors: a patent review
- Novel therapies in acute and chronic heart failure
- Decreasing Arterial Stiffness and/or Wave Reflections Independently of Mean Arterial Pressure: Effect of Non-antihypertensive Drugs (Part 2)
- Serum carboxymethyl-lysine, a dominant advanced glycation end product, is associated with chronic kidney disease: the Baltimore longitudinal study of aging
- Lens fluorescence and accommodative amplitude in pre-presbyopic and presbyopic subjects
- Arterial Stiffness and Hypertension–Which Comes First?
- Coronary microvascular disease as an early culprit in the pathophysiology of diabetes and metabolic syndrome
- Foreseeable and more distant rejuvenation therapies
- Role of oxidative stress and targeted antioxidant therapies in experimental models of diabetic complications
- Reduction of advanced-glycation end products levels and inhibition of RAGE signaling decreases rat vascular calcification induced by diabetes
- Alagebrium Mitigates Metabolic Insults in High Carbohydrate and High Fat Diet Fed Wistar Rats
- Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension
- Is human aging still mysterious enough to be left only to scientists?
- Peel extract of water chestnut (Trapa bispinosa Roxb.) inhibits glycation, degradesα-dicarbonyl compound, and breaks advanced glycation end product …
- Heart failure with normal left ventricular ejection fraction: what is the evidence?
- Arterial stiffness as a measure of vascular dysfunction in hypertensive women
- Pharmacological modulation of arterial stiffness
- Elevated pulse pressure, intraoperative hemodynamic perturbations, and acute kidney injury after coronary artery bypass grafting surgery
- Is increased arterial stiffness a cause or consequence of atherosclerosis?
- A strategy for postponing aging indefinitely
- Alagebrium inhibits neointimal hyperplasia and restores distributions of wall shear stress by reducing downstream vascular resistance in obese and diabetic rats
- Correlates of aortic stiffness progression in patients with type 2 diabetes: importance of glycemic control: the Rio de Janeiro type 2 diabetes cohort study
- Heart failure in type 2 diabetes mellitus: impact of glucose-lowering agents, heart failure therapies, and novel therapeutic strategies
- Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions
- Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering
- Cardiovascular effects of 1 year of alagebrium and endurance exercise training in healthy older individuals
- The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond
- Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness
- Pathophysiology and medical treatment of carotid artery stenosis
- Reversing chronic remodeling in heart failure
- Role of arterial stiffness in cardiovascular disease
- Free radicals in aging: causal complexity and its biomedical implications
- 7Uncertainty quantification and
- Advanced glycation: how are we progressing to combat this web of sugar anomalies in diabetic nephropathy
- Pharmacologic approaches to reduce arterial stiffness
- Using Diet-induced Obesity to Examine the Role for Advanced Glycation End-products in Metabolic Osteoarthritis Pathogenesis in Young Rats
- Advanced glycation end-products induce basement membrane hypertrophy in endoneurial microvessels and disrupt the blood–nerve barrier by stimulating …
- A Study to Evaluate the Associated Systemic Risk Factors in Type 2 Diabetes Mellitus patients with Clinically Significant Macular Edema
- The role of fibrinogen glycation in ATTR: evidence for chaperone activity loss in disease
- Advanced glycation end products: role in pathology of diabetic cardiomyopathy
- Targeting Blood Pressure Lowering and the Sympathetic Nervous System
- Therapies for hyperglycaemia-induced diabetic complications: from animal models to clinical trials
- Advanced glycation end products and the kidney
- Sex-specific association of age with carotid artery distensibility: multi-ethnic study of atherosclerosis
- Aortic stiffness in aging and hypertension: prevention and treatment with habitual aerobic exercise
- Age associated changes of AGE-receptor expression: RAGE upregulation is associated with human heart dysfunction
- Role of Amino Acids on Prevention of Nonenzymatic Glycation of Lens Proteins in Senile and Diabetic Cataract
- The glycation pathway in type 2 diabetes and cardiovascular disease
- Arterial stiffness, its assessment, prognostic value, and implications for treatment
- The Role of Advanced Glycation in Diabetic Retinopathy
- Advanced glycation end products (AGEs) in diabetes
- Soluble receptor for advanced glycation end-products independently influences individual age-dependent increase of arterial stiffness
- Endocrine and molecular influences on testicular development in Meishan and White Composite boars
- Regional arterial stiffness in patients with type 2 diabetes and chronic kidney disease
- Research for Vascular Failure: Current Topics in China
- Myocardial infarction, heart failure and sympathetic nervous system activity: new pharmacological approaches that affect neurohumoral activation
- Discussion and future perspectives
- Advanced glycation end products and their circulating receptors predict cardiovascular disease mortality in older community-dwelling women
- Pulse pressure and adverse outcomes in women: a report from the Women’s Ischemia Syndrome Evaluation (WISE)
- Cardiac overexpression of antioxidant catalase attenuates aging-induced cardiomyocyte relaxation dysfunction
- New Approach to Preventing and Treating Diabetes Mellitus: Focus on Advanced Glycation End Products (AGE)
- Skin autofluorescence in diabetes mellitus
- Basic Science for Clinicians
- Current perspectives on the health risks associated with the consumption of advanced glycation end products: recommendations for dietary management
- Skin autofluorescence and pentosidine are associated with aortic stiffening: The Maastricht Study
- The Evolving Face of Heart Failure Associated with Elevated Cardio-Metabolic Risk Factors
- Dietary advanced glycation end-products: molecular mechanisms and preventive tools
- Pyridoxamine prevents age-related aortic stiffening and vascular resistance in association with reduced collagen glycation
- Aldosterone receptor inhibition alters the viscoelastic biomechanical behavior of the aortic wall
- Arterial remodeling and hypertensive damage: Clinical studies in patients with essential hypertension
- High serum levels of advanced glycation end products predict increased coronary heart disease mortality in nondiabetic women but not in nondiabetic men: a …
- Reduction of renal tubular injury with a RAGE inhibitor FPS-ZM1, valsartan and their combination in streptozotocin-induced diabetes in the rat
- Antihypertensive treatment alters the predictive strength of pulse pressure and other blood pressure measures
- Effects of supervised exercise and dietary nitrate in older adults with controlled hypertension and/or heart failure with preserved ejection fraction
- Medical treatment of diabetic retinopathy
- Cardiac-specific overexpression of insulin-like growth factor 1 attenuates aging-associated cardiac diastolic contractile dysfunction and protein damage
- Advanced glycation endproduct-induced diabetic complications
- Stimulatory effects of non-enzymatic glycation on fibronectin matrix assembly
- Protein glycation: a firm link to endothelial cell dysfunction
- Diabetic cardiomyopathy: A new perspective of mechanistic approach
- Advanced glycation end products are associated with inflammation and endothelial dysfunction in HIV
- The development of maillard reaction, and advanced glycation end product (AGE)-receptor for AGE (RAGE) signaling inhibitors as novel therapeutic strategies for …
- Advanced glycation end products and diabetic cardiovascular disease
- A novel improved therapy strategy for diabetic nephropathy: targeting AGEs
- Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology
- The glymphatic system and waste clearance with brain aging: a review
- Role of methylglyoxal in the pathogenesis of insulin resistance
- Pre-Diabetes, Cardiovascular Risk Factors, Arterial Stiffness—ADMA: Mechanisms of Pre-Diabetes and Diabetes: Modulation of Cardiac Tissues
- Renal nerve ablation reduces augmentation index in patients with resistant hypertension
- Receptor for advanced glycation end-products (RAGE) and soluble RAGE (sRAGE): cardiovascular implications
- Advanced glycation end products and risks for chronic diseases: intervening through lifestyle modification
- Regional arterial stiffness associated with ischemic heart disease in type 2 diabetes mellitus
- Prevention of vascular complications in diabetes mellitus patients: focus on the arterial wall
- Vascular aging: a tale of EVA and ADAM in cardiovascular risk assessment and prevention
- Novel drug treatment for diabetic nephropathy
- Treatment and control of high blood pressure in adults
- Advanced glycation endproducts regulate smooth muscle cells calcification in cultured HSMCs
- Molecular mechanisms of vascular dysfunction and cardiovascular biomarkers in type 2 diabetes
- Aging hearts and vessels: masters of adaptation and survival
- Limited joint mobility (LJM) in elderly subjects with type II diabetes mellitus
- Proinflammation of aging central arteries: a mini-review
- Clinical potential of advanced glycation end-product inhibitors in diabetes mellitus
- Reduced wall compliance suppresses Akt-dependent apoptosis protection stimulated by pulse perfusion
- Modulation of advanced glycation endproducts (AGEs) signaling in experimentally induced stroke in mice.
- Curcumin ameliorates arterial dysfunction and oxidative stress with aging
- Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats
- Characterizing the advanced glycation endproducts formation of proteins and nucleotides by methylglyoxal and glyoxal
- Structural alterations in arterial stiffness: role of arterial fibrosis
- Structural and functional properties, chaperone activity and posttranslational modifications of alpha-crystallin and its related subunits in the crystalline lens: N …
- Arterial Destiffening With Weight Loss in Overweight and Obese Middle-Aged and Older Adults
- Arterial stiffness in the heart disease of CKD
- Uremic toxicity of advanced glycation end products in CKD
- Peel extract of water chestnut (Trapa bispinosa Roxb.) inhibits glycation, degradesα-dicarbonyl compound, and breaks advanced glycation end product crosslinks
- Exercise, advanced glycation end products, and their effects on cardiovascular disorders: A narrative review
- Advanced glycation end products upregulate lysyl oxidase and endothelin-1 in human aortic endothelial cells via parallel activation of ERK1/2–NF-κB and JNK–AP-1 …
- Study of advanced glycation endproducts (AGEs) of human fibrinogen and nucleobases with methyl glyoxal: An in vitro investigation of ages formation
- Pharmacological and non-pharmacological treatment of endothelial dysfunction: relevance to diabetes
- AGE/non-AGE glycation: An important event in rheumatoid arthritis pathophysiology
- RAGE: a multi-ligand receptor unveiling novel insights in health and disease
- Matrix metalloproteinase 2 activation of transforming growth factor-β1 (TGF-β1) and TGF-β1–type II receptor signaling within the aged arterial wall
- Advanced glycation end-products (AGEs) and their soluble receptor (sRAGE) in women suffering from systemic lupus erythematosus (SLE)
- Vascular changes in type 2 diabetes mellitus: Application to restenosis after stenting
- Apparent treatment-resistant hypertension and chronic kidney disease: another cardiovascular-renal syndrome?
- Glycation and Glycosylation in Cardiovascular Remodeling: Focus on Advanced Glycation End Products and O-Linked Glycosylations as Glucose-Related …
- Do advanced glycation end products and its receptor play a role in pathophysiology of hypertension?
- Advanced glycation end products (AGEs) and its receptor, RAGE, modulate age-dependent COVID-19 morbidity and mortality. A review and hypothesis
- Preservation of pressure-induced cutaneous vasodilation by limiting oxidative stress in short-term diabetic mice
- AGE-RAGE Axis in the Aging and Diabetic Heart
- Quantitative analysis of the effect of diabetes on fibroflast migration
- The roles of protein glycation, glycoxidation, and advanced glycation end-product formation in diabetes-induced atherosclerosis
- Uremic toxin–targeting as a therapeutic strategy for preventing cardiorenal syndrome
- Diastolic dysfunction of aging is independent of myocardial structure but associated with plasma advanced glycation end-product levels
- Evolution and modulation of age-related medial elastocalcinosis: impact on large artery stiffness and isolated systolic hypertension
- Contribution of receptor for advanced glycation end products to vasculature-protecting effects of exercise training in aged rats
- Endurance exercise training attenuates fibrosis and collagen cross-linking in myocardium of aged rats
- Effects of hot water extract of mangosteen pericarp on vascular function: Re-analysis focusing on factors affecting vascular function
- Aortic stiffness: epidemiology, risk factors, and relevant biomarkers
- The evolution of systolic blood pressure as a strong predictor of cardiovascular risk and the effectiveness of fixed-dose ARB/CCB combinations in lowering levels of …
- Diabetes with heart failure increases methylglyoxal modifications in the sarcomere, which inhibit function
- Arterial stiffness: a potential therapeutic target to reduce cardiovascular mortality
- PRECLINICAL STUDIES ON PTEROSTILBENE FOR DIABETIC CARDIOMYOPATHY
- The role of collagen crosslinks on passive cardiac mechanics in volume-overload hypertrophy
- Mechanisms, pathophysiology, and therapy of arterial stiffness
- Pyridoxamine ameliorates the effects of advanced glycation end products on subtotal nephrectomy induced chronic renal failure rats
- Protein glycation and oxidative stress in pathophysiology of diabetic complications
- Diastolic dysfunction in hypertension
- Arterial stiffness and cardiovascular therapy
- Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a “set up” for vascular disease
- Aminoguanidine prevents fructose-induced arterial stiffening in Wistar rats: aortic impedance analysis
- Arterial aging: is it an immutable cardiovascular risk factor?
- Ischemia-modified albumin is associated with arterial stiffness in hemodialysis patients
- Can targeting the incretin pathway dampen RAGE-mediated events in diabetic nephropathy?
- Aging and arterial stiffness
- The central arterial burden of the metabolic syndrome is similar in men and women: the SardiNIA Study
- Heart failure with preserved ejection fraction: is there a passage between Scylla and Charybdis?
- Chronic kidney disease as a risk factor for heart failure with preserved ejection fraction: a focus on microcirculatory factors and therapeutic targets
- Substrate stiffness regulates PDGF-induced circular dorsal ruffle formation through MLCK
- Identification and characterization of enzymes responsible for methylglyoxal overproduction in the metabolic syndrome
- High-molecular-weight advanced glycation end products disturb the vasomotor balance in rat aortic rings through superoxide formation
- Advanced glycation end products: potential mechanism and therapeutic target in cardiovascular complications under diabetes
- Prognostic impact of changes in aortic stiffness for cardiovascular and mortality outcomes in individuals with type 2 diabetes: the Rio de Janeiro cohort study
- Arterial destiffening with atorvastatin in overweight and obese middle-aged and older adults
- The role of titin and extracellular matrix remodelling in heart failure with preserved ejection fraction
- The importance of mechanical forces for in vitro endothelial cell biology
- The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review
- Brachial pressure–independent reduction in carotid stiffness after long-term angiotensin-converting enzyme inhibition in diabetic hypertensives
- Influence of regular exercise on age-related changes in arterial elasticity: mechanistic insights from wall compositions in rat aorta
- Targeting the arterial wall, but what is the target?
- Age-related changes in the mechanical properties of large arteries
- Localised micro-mechanical stiffening in the ageing aorta
- Advanced glycation end products: A potential contributor of oxidative stress for cardio-vascular problems in diabetes
- Heart failure with normal ejection fraction
- Advanced glycation end products and oxidative stress in a hyperglycaemic environment
- New therapeutic agents for diabetic kidney disease
- 9 Cardiovascular Changes with Aging
- Methylglyoxal, oxidative stress, and aging
- Role of advanced glycation end products in carcinogenesis and their therapeutic implications
- Central arterial aging: humans to molecules
- Multiphoton imaging of induced autofluorescent advanced glycation end products in porcine aorta
- AGEs induce ectopic endochondral ossification in intervertebral discs
- Heart, aging, and hypertension
- Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury
- Advanced glycation end products present in the obese uterine environment compromise preimplantation embryo development
- Multiphoton imaging of autofluorescent advanced glycation end product formation in porcine aorta
- Arterial stiffness as a cause of resistant hypertension?
- Dietary glycotoxins and infant formulas
- Diabetic patients and kidney protection: an attainable target
- Advanced glycation end products in diabetic retinopathy and phytochemical therapy
- A meta-analysis of the mechanism of blood pressure change with aging
- Pioglitazone improves aortic wall elasticity in a rat model of elastocalcinotic arteriosclerosis
- Wall stiffness suppresses Akt/eNOS and cytoprotection in pulse-perfused endothelium
- Ascorbic acid selectively improves large elastic artery compliance in postmenopausal women
- Bibliography Current World Literature Vol 23 No 4 July 2008
- Role of titin and collagen in the diastolic dysfunction of cirrhotic cardiomyopathy
- Glycoxidative stress and cardiovascular complications in experimentally-induced diabetes: effects of antioxidant treatment
- Matrix metalloproteinase-3 genotype contributes to age-related aortic stiffening through modulation of gene and protein expression
- Arterial stiffness in chronic inflammatory diseases
- Aortic stiffness is reduced beyond blood pressure lowering by short-term and long-term antihypertensive treatment: a meta-analysis of individual data in 294 patients
- Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are correlated with AGEs in both diabetic and non-diabetic subjects
- Arterioventricular coupling and ventricular efficiency after antihypertensive therapy: a noninvasive prospective study
- Skin autofluorescence relates to soluble receptor for advanced glycation end-products and albuminuria in diabetes mellitus
- A hypothesis: moderate consumption of alcohol contributes to lower prevalence of type 2 diabetes due to the scavenging of alpha-dicarbonyls by dietary polyphenols
- The reality of aging viewed from the arterial wall
- Aortic Stiffness: Review of Life Course, Epidemiology, Risk Factors, and Relevant Biomarkers
- Cardiovascular Changes with Aging
- 24 Carotid intima–media thickness and arterial stiffness: indicators of cardiovascular risk and modifications by treatment
- Cardiac Specific Overexpression of Insulin-Like Growth Factor-1 (IGF-1) Attenuates Aging-Associated Cardiac Diastolic Contractile Dysfunction and Protein Damage
- Sex differences in age-related stiffening of the aorta in subjects with type 2 diabetes
- Basic and clinical research against advanced glycation end products (AGEs): new compounds to tackle cardiovascular disease and diabetic complications
- Stiffness-induced endothelial DLC-1 expression forces leukocyte spreading through stabilization of the ICAM-1 adhesome
- New antihypertensive drugs under development
- Effect of Citrullus colocynthis extract on glycated hemoglobin formation (in vitro)
- MRI and Echo Assessment of the Diastolic Dysfunction of Normal Aging: Altered LV Pressure Decline or Load?
- Aldose reductase regulates hyperglycemia-induced HUVEC death via SIRT1/AMPK-α1/mTOR pathway
- Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets
- CHRONIC LOW INTENSITY CONTINUOUS AND INTERVAL TRAINING PREVENT HEART FAILURE-RELATED CORONARY ARTERY STIFFNESS
- Dynamic changes in myocardial matrix and relevance to disease: translational perspectives
- Functional aortic stiffness: role of CD4+ T lymphocytes
- Assessment of vascular wall shear stress and implications for atherosclerotic disease
- VU Research Portal
- Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve …
- Causes and consequences of increased arterial stiffness in chronic kidney disease patients
- Role of antihypertensive drugs in arterial ‘de-stiffening’and central pulsatile hemodynamics
- Identifying and interpreting novel targets that address more than one diabetic complication: a strategy for optimal end organ protection in diabetes
- Review paper Arterial stiffness as a new marker for cardiovascular disease
- Arterial stiffness and hypertension: emerging concepts
- Ultrasonic delineation of aortic microstructure: the relative contribution of elastin and collagen to aortic elasticity
- The metabolic syndrome, cardiopulmonary fitness, and subcutaneous trunk fat as independent determinants of arterial stiffness: the Amsterdam Growth and Health …
- Nitric oxide and the regulation of large artery stiffness: from physiology to pharmacology
- Strategies for achieving healthy vascular aging
- The role of titin and extracellular matrix remodelling in HFpEF
- Pathogenesis of elevated peripheral pulse pressure: some reflections and thinking forward
- Nuclear Expression and DNA Binding Capacity of Receptor for Advanced Glycation End Products in Renal Tissue
- Aging and arterial structure-function relations
- Determinants of progression of aortic stiffness in hemodialysis patients: a prospective longitudinal study
- Arterial compliance of rowers: implications for combined aerobic and strength training on arterial elasticity
- Relation of diabetes to coronary artery ectasia: A meta-analysis study.
- Perivascular adipose tissue-mediated arterial stiffening in aging and disease: An emerging translational therapeutic target?
- Glycoxidation and diabetic complications: modern lessons and a warning?
- Structural remodeling in the limb circulation: impact of obesity and diabetes
- Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: an update
- Trends in advanced glycation end products research in diabetes mellitus and its complications
- Effects of low‐level light therapy on hepatic antioxidant defense in acute and chronic diabetic rats
- Clinical studies on coronary revascularization in patients with type 2 diabetes
- Regenerative therapies for diabetic microangiopathy
- Obesity, arterial stiffness, and cardiovascular risk
- Glyoxalase 1 modulation in obesity and diabetes
- Increased central arterial stiffness after spinal cord injury: contributing factors, implications, and possible interventions
- Central and peripheral blood pressures in relation to plasma advanced glycation end products in a Chinese population
- Prevention of protein glycation by nanoparticles: potential applications in T2DM and associated neurodegenerative diseases
- Cardiovascular disease: what’s all the AGE/RAGE about?
- Advanced Glycation End Products And Risks For Chronic Diseases: Intervening Through Lifestyle Modification
- Unfavorable effects of resistance training on central arterial compliance: a randomized intervention study
- High blood pressure and pulse pressure
- Arterial stiffness and cardiovascular risk in hypertension
- Advanced glycation end products and diabetic complications
- Aortic input impedance increases with age in healthy men and women
- Interaction between pulse wave velocity, augmentation index, pulse pressure and left ventricular function in chronic heart failure
- AGE-RAGE Axis in the Aging and Diabetic Heart: Prime Target for Adjunctive Therapeutic Intervention
- The age-related macular degeneration as a vascular disease: Contributions to the non-pharmacological interventions and pharmacological therapy arising from …
- Treatment of arterial remodeling in essential hypertension
- Linking diabetes and atherosclerosis
- Age-related changes in venticular–arterial coupling: pathophysiologic implications
- Arterial stiffness gradient
- A population-based assessment of 24-hour ocular perfusion pressure among patients with primary open angle glaucoma: the Handan Eye Study
- Association of 276G> T adiponectin gene polymorphism to plasma adiponectin and albuminuria in type 2 diabetic patients
- Glucose and blood pressure-dependent pathways–the progression of diabetic kidney disease
- Characteristics of rabbit ClC-2 current expressed in Xenopus oocytes and its contribution to volume regulation
- Glycated collagen I induces premature senescence-like phenotypic changes in endothelial cells
- Hypertension induces brain β-amyloid accumulation, cognitive impairment, and memory deterioration through activation of receptor for advanced glycation end …
- Aspects of hyperglycemia contribution to arterial stiffness and cardiovascular complications in patients with type 1 diabetes
- Pulse pressure and coronary atherosclerosis progression in postmenopausal women
- Angiotensin II contributes to arterial compliance in congestive heart failure
- Therapeutic potential of vitamin D in AGE/RAGE-related cardiovascular diseases
- The role of fibrinogen glycation in ATTR: evidence for chaperone activity loss in
- Drugs and the peroxisome proliferator activated receptors
- Endothelial dysfunction and arterial stiffness in coronary artery disease
- Will new antihypertensive drugs emerge? Part 1
- Arterial elasticity in cardiovascular disease: focus on hypertension, metabolic syndrome and diabetes
- In vitro system to study realistic pulsatile flow and stretch signaling in cultured vascular cells
- Mesenchymal stem cells: a future experimental exploration for recession of diabetic nephropathy
- Halting arterial aging in patients with cardiovascular disease: hypolipidemic and antihypertensive therapy
- Oxidative Stress in Retinal Diseases
- Similarities and differences between the pathogenesis and pathophysiology of diastolic and systolic heart failure
- Vascular stiffness and increased pulse pressure in the aging cardiovascular system
- Left Ventricular Diastolic Dysfunction in Essential Hypertension,’Evaluation by Doppler Echocardiography’
- Aortic stiffness as a surrogate endpoint to micro-and macrovascular complications in patients with type 2 diabetes
- A comparative study on skin and plasma advanced glycation end products and their associations with arterial stiffness
- Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation
- Current concepts in targeted therapies for the pathophysiology of diabetic microvascular complications
- Does vascular elasticity affect arteriovenous fistula maturation?
- Remodeling of heterogeneous extracellular matrices of the diabetic nerve: Models and experiments
- Leg flow-mediated arterial dilation in elderly patients with heart failure and normal left ventricular ejection fraction
- Ventriculovascular coupling in systolic and diastolic heart failure
- Clinical Implication of Vascular Calcification in Patients Undergoing Hemodialysis: The End or the Beginning of Disease
- Arginase inhibition alleviates hypertension associated with diabetes: effect on endothelial dependent relaxation and NO production
- Arterial de-stiffing Drugs: Which Promising Therapeutic Agent is Useful?
- Heart failure with preserved ejection fraction: the new devil in the pandemic
- Arterial stiffness and coronary ischemic disease
- Characterization of cardiac time intervals in healthy bonnet macaques (Macaca radiata) by using an electronic stethoscope
- Advanced glycation end products: new clinical and molecular perspectives
- A comparative study of levels of methylglyoxal and reduced glutathione in different organs of rats treated with high carbohydrate diets
- Increased arterial stiffness is independently related to cerebrovascular disease and aneurysms of the abdominal aorta: the Second Manifestations of Arterial Disease …
- Multi-modal magnetic resonance imaging quantifies atherosclerosis and vascular dysfunction in patients with type 2 diabetes mellitus
- Ventriculovascular coupling in systolic and diastolic heart failure
- Endothelial dysfunction: a contributor to adverse cardiovascular remodeling and heart failure development in type 2 diabetes beyond accelerated atherogenesis
- Aortic stiffness: current understanding and future directions
- Effets d’une prise unique de flavanols du cacao sur la réactivité vasculaire périphérique chez des patients atteints de diabète de type 2
- Pathogenesis and pathophysiology of diabetic nephropathy
- Determinants of increasing pulse pressure during 23 years’ follow‐up as a marker of arterial stiffness and vascular ageing
- The vascular endothelium in diabetes: a practical target fordrug treatment?
- Anti-atherosclerotic effects of sitagliptin in patients with type 2 diabetes mellitus
- Different role of wave reflection magnitude and timing on left ventricular mass reduction during antihypertensive treatment
- AGE and RAGE inhibitors in the treatment of diabetic retinopathy
- The Effects of Weight Gain and Atorvastatin Treatment on Arterial Stiffness
- Vascular stiffness: its measurement and significance for epidemiologic and outcome studies
- Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes: a role for mitochondria and the nuclear factor-E2-related factor 2-Kelch-like …
- The pathobiology of diabetic vascular complications—cardiovascular and kidney disease
- Regular exercise, hormone replacement therapy and the age-related decline in carotid arterial compliance in healthy women
- Aortic pulse wave velocity and albuminuria in patients with type 2 diabetes
- Vascular endothelial dysfunction in diabetic cardiomyopathy: pathogenesis and potential treatment targets
- The role of renin–angiotensin–aldosterone system inhibition in chronic kidney disease
- Risk stratification
- Arterial Stiffness and Coronary Ischemic
- Characteristics of arterial stiffness in very low birth weight premature infants
- MRI and echocardiographic assessment of the diastolic dysfunction of normal aging: altered LV pressure decline or load?
- Mechanisms of disease: the oxidative stress theory of diabetic neuropathy
- Walking may be related to less vascular stiffness in the Activity Counseling Trial (ACT)
- Associations of cardiovascular disease risk factors and calcified atherosclerosis with aortoiliac bifurcation position: the multiethnic study of atherosclerosis
- International Journal of Diabetes & Metabolic Disorders
- Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive …
- Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E–null mice
- Aortic correlates of clinical markers of large artery structure and function. Effects of aging and hypertension
- Obesity in a model of haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy
- Diabetic microangiopathy—etiopathogenesis, new possibilities in diagnostics and management
- Oxidative stress implication in retinal diseases—A review
- New approaches to the treatment of nephropathy in diabetes
- Distinct myocardial targets for diabetes therapy in heart failure with preserved or reduced ejection fraction
- Healthy lifestyle-based approaches for successful vascular aging
- Carotid stiffness indicates risk of ischemic stroke and TIA in patients with internal carotid artery stenosis: the SMART study
- All-extremity exercise training improves arterial stiffness in older adults
- Transforming growth factor β in hypertensives with cardiorenal damage
- Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study
- Premature coronary artery disease and arterial stiffness: too soon to speculate?
- 1.2. 4 Vascular remodelling
- Arterial stiffening as a possible risk factor for both atherosclerosis and diastolic heart failure
- Arterial aging: a review of the pathophysiology and potential for pharmacological intervention
- Arterial stiffness: a novel cardiovascular risk factor in kidney disease patients
- The role of arterial stiffness in stratifying the overall cardiovascular risk
- Atherosclerosis, arterial stiffness and antihypertensive drug therapy
- Estimated aortic stiffness is independently associated with cardiac baroreflex sensitivity in humans: role of ageing and habitual endurance exercise
- Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome
- Skin Autofluorescence Relates to Soluble Receptor for Advanced Glycation End-Products and Albuminuria in Diabetes Mellitus
- Interrelationship between diabetes mellitus and heart failure: The role of peroxisome proliferator-activated receptors in left ventricle performance
- Preclinical aortic atherosclerosis in adolescents with chronic disease
- Aortic correlates of clinical markers of large artery structure and function. Effects of aging and hypertension
- Differential Gene Transcription in Monocytes from Chronic Kidney Disease and Healthy Patients
- Imaging in diabetic cardiomyopathy
- SIRT1-DEPENDENT CYTOPROTECTIVE EFFECTS OF RESVERATROL IN HIGH GLUCOSE-CHALLENGED HUMAN ENDOTHELIAL CELLS INVOLVES …
- Central blood pressures: do we need them in the management of cardiovascular disease? Is it a feasible therapeutic target?
- Effect of unilateral resistance training on arterial compliance in elderly men
- Arterial Stiffness as a Cardiovascular Risk Factor for the Development of Preeclampsia and Pharmacopreventive Options
- Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE
- AGEs induce oxidative stress and activate protein kinase C-βII in neonatal mesangial cells
- Heart failure with normal ejection fraction: consideration of mechanisms other than diastolic dysfunction
- Food-related carbonyl stress in cardiometabolic and cancer risk linked to unhealthy modern diet
- Endothelial Dysfunction in Diabetes: An Update on Mechanisms and Therapeutic Targets
- Cardiovascular calcifications in old age: mechanisms and clinical implications
- High ambient glucose augments angiotensin II-induced proinflammatory gene mRNA expression in human mesangial cells: effects of valsartan and simvastatin
- Arterial stiffness and systolic hypertension: determinants, assessment, and clinical consequences
- Advanced glycation end products, rage, and aging
- Noninvasive assessment of arterial stiffness and risk of atherosclerotic events
- Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population …
- New therapy approach in heart failure with preserved ejection fraction based on new pathophysiological concept
- Dynamic Changes in Myocardial Matrix and Relevance to Disease
- Glucose-and non-glucose-induced mitochondrial dysfunction in diabetic kidney disease
- Altered proximal aortic stiffness and endothelin plasma levels in diabetic patients with end-stage renal disease
- Elevated plasma B-type natriuretic peptide concentration and resistive index, but not decreased aortic distensibility, associate with impaired blood flow at popliteal …
- Nitric oxide regulates transforming growth factor-β signaling in endothelial cells
- The early life origins of vascular ageing and cardiovascular risk: the EVA syndrome
- Cardiology Research and Practice
- Arterial stiffness and hypertension in the elderly
- Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review
- Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects
- Small artery remodeling in obesity and insulin resistance
- Arterial stiffness: A review in type 2 diabetes
- Oxidative stress-related mechanisms and antioxidant therapy in diabetic retinopathy
- Potential mechanisms underlying the association between type II diabetes mellitus and cognitive dysfunction in rats: a link between miRNA-21 and …
- Mechanics and function of the pulmonary vasculature: implications for pulmonary vascular disease and right ventricular function
- The effects of changes in the metabolic syndrome detection status on arterial stiffening: a prospective study
- Skin autofluorescence as a marker of cardiovascular risk in children with chronic kidney disease
- Novel pharmacological treatments for heart failure
- Relationship between upper and lower limb conduit artery vasodilator function in humans
- Women want the heavens, men want the earth
- Targeting Signaling Pathways
- Hypertension and chronic kidney disease: respective contribution of mean and pulse pressure and arterial stiffness
- Cardiovascular Disease in the Elderly
- Insulin resistance: the cardiovascular aspect
- Effects of 3-months sitting callisthenic balance and resistance exercise on aerobic capacity, aortic stiffness and body composition in healthy older participants …
- Systolic blood pressure response to exercise in type 1 diabetes families compared with healthy control individuals
- Hemoglobin A1c and arterial and ventricular stiffness in older adults
- Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes
- Time-efficient physical training for enhancing cardiovascular function in midlife and older adults: promise and current research gaps
- Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans
- Hyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes
- Arterial stiffness and stroke in hypertension: therapeutic implications for stroke prevention
- Central blood pressure as a risk marker for cardiovascular complications
- Vascular and metabolic response to isolated small muscle mass exercise: effect of age
- Diabetic cardiovascular disease induced by oxidative stress
- Arterial stiffness
- Skin autofluorescence is associated with the progression of chronic kidney disease: a prospective observational study
- Vascular effects of diabetes mellitus
- Effect of exercise training and weight loss on arterial stiffness and pulsatile hemodynamics
- Central Blood Pressure Parameters Correlate with Cardiac Structure and Function in Healthy Chinese Individuals without Cardiovascular Disease
- Mechanisms Involved in Premature Aging in the Heart—Is There an Implication for Cardiac Surgery?
- Cardiovascular adaptations to exercise training in older women with and without type 2 diabetes mellitus
- Probiotic Supplementation, The Gut Microbiota, and Cardiovascular Health
- Left ventricular diastolic dysfunction in dialysis patients assessed by novel speckle tracking strain rate analysis: prevalence and determinants
- Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies
- Effect of aging on metabolic pathways in endothelial progenitor cells
- Vascular Stem and Progenitor Cells in Diabetic Complications
- Neurodegeneration is dependant on microglial proximity and nitric oxide production
- Treatment of heart failure with normal ejection fraction: an inconvenient truth!
- Specific aspects of high blood pressure in the elderly
- Treatment of heart failure with preserved systolic function in the elderly
- Validation of carotid artery tonometry as a means of estimating augmentation index of ascending aortic pressure
- Novel therapies in heart failure
- Pulse wave analysis and diabetes mellitus. A systematic review.
- VASCULAR BIOLOGY-HEMODYNAMICS-HYPERTENSION Arterial stiffness in predialysis patients with uremia.
- Blood pressure and arterial load after transcatheter aortic valve replacement for aortic stenosis
- Heart failure in the elderly: advances and challenges
- Role of aging and aerobic fitness on large elastic artery stiffness, brain structure and cognitive performance in humans
- Renin-angiotensin-aldosterone system blockade in diabetic nephropathy. Present evidences
- The effects of strength training on arterial structure and function in middle-aged and older adults
- The effect of aerobic exercise on pulse wave velocity in middle-aged and elderly people: a systematic review and meta-analysis of randomized controlled …
- Lifetime risks for cardiovascular disease mortality by cardiorespiratory fitness levels measured at ages 45, 55, and 65 years in men: the Cooper Center Longitudinal …
- Dialysis initiation and clinical outcomes in chronic kidney disease: Role of education and biomarkers
- Cardiovascular dysfunction in experimental diabetes: effect of treatment with insulin and chromium
- Novel Treatments in Diabetic Nephropathy
- Advanced glycation end-products and outcome in heart failure patients with preserved and reduced ejection fraction
- Studies of vascular function in patients with heart failure and either preserved or reduced left ventricular systolic function
- Complimentary and personal copy for Mariko Takenokuchi, Kinuyo Matsumoto, Yuko Nitta, Rumi Takasugi, Yukari Inoue, Michi Iwai, Keiichi Kadoyama
- Interaction between mean arterial pressure and HbA1c in prediction of cardiovascular disease hospitalisation: a population-based case-control study
- The Arterial Pulse: Vascular Biology, Vascular Function Testing, and Therapies
- Age-associated changes in the cardiovascular system
- The vascular endothelium in diabetes—a therapeutic target?
- The future of antihypertensive treatment: from myth to imminent reality
- Is longitudinal pulse pressure a better predictor of 24-hour urinary albumin excretion than other indices of blood pressure?
- Role of increased aortic stiffness in the pathogenesis of heart failure
- Exercise and arterial adaptation in humans: uncoupling localized and systemic effects
- Use of pulse pressure method for estimating total arterial compliance in vivo
- Occasional Survey Arterial Stiffness in Children and Teenagers: An Emerging Cardiovascular Risk Factor
- Normal aging of the cardiovascular system
- Update on the treatment of diabetic retinopathy
- Effects of exercise modalities on arterial stiffness and wave reflection: a systematic review and meta-analysis of randomized controlled trials
- Preserved α-Adrenergic tone in the leg vascular bed of spinal cord–injured individuals
- Clinical studies of advanced glycation end product inhibitors and diabetic kidney disease
- The stroke volume/pulse pressure ratio predicts coronary heart disease mortality in a population of elderly men
- Dr. Russell S. Richardson Medical Teaching Facility 9500 Gilman Drive La Jolla, CA 92093-0623
- Effects of aging and exercise training on structural and vasoconstrictor properties of skeletal muscle arterioles
- The prevalence of preclinical atherosclerosis in a healthy adult population
- Therapeutic Advances in Cardiovascular Disease
- Diabetes mellitus and aorta: does size matter?
- Basic Mechanisms Mediating Cardiomyopathy and Heart Failure in Aging
- VU Research Portal
- Treatment of patients with heart failure and preserved ejection fraction
- Nonenzymatic glycosylation and the pathogenesis of diabetic complications
- Pulse pressure and risk for myocardial infarction and heart failure in the elderly
- The pulse pressure-to-stroke index ratio predicts cardiovascular events and death in uncomplicated hypertension
- Pulse Wave Velocity is an Independent Predictor of Office Hypertension
- The impact of the 24-h movement spectrum on vascular remodeling in older men and women: a review
- Diabetes and the Cardiovascular System
- Ambulatory monitoring of the cardiovascular system: the role of pulse wave velocity
- Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease
- Glycation, antiglycation, and deglycation: Their role in aging mechanisms and geroprotective effects (literature review)
- The Roles of Oxidative Stress, Inflammation and Adaptive Immunity in Aortic Stiffening
- The aging hypertensive heart: a brief update
- Mechanisms of kidney fibrosis and the role of antifibrotic therapies
- DF-5 compound delays development of diabetic nephropathy in rats
- Infarcted Rat Myocardium
- Measurement of advanced glycation end products in the skin using autofluorescence spectroscopy in patients with chronic kidney disease
- Vascular Rho-related BTB Domain-containing Protein 1 (RhoBTB1) in Hypertension and Aortic Stiffness
- AGEing and osteoarthritis: a different perspective
- A vessel age. Mechanisms of vessel wall ageing. Methods of assessment
- Immune modulation of vascular stiffening
- Accumulation of Advanced Glycation End Products, Measured by Skin Auto-fluorescence is Associated with Presence and Number of Diabetes Complications; …
- Coronary Microvascular Disease as an Early Culprit in
- Arterial rigidity and central pressure: novel aspects of pathophysiology and therapy
- Gene regulatory networks: modeling, intervention and context
- Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension
- Fructosamine 3-kinase and glyoxalase I polymorphisms and their association with soluble RAGE and adhesion molecules in diabetes
- Advanced glycoxidation: A new risk factor for cardiovascular disease?
- Pulse pressure partially explains the higher incidence of cardiovascular disease associated with advanced glycation endproducts and low-grade inflammation …
- Ab initio Study on Benzoin Condensation Catalysed by Alagebrium in order to Test for Alagebrium’s Potential as a Thiamine Supplement
- Molekulare Grundlagen altersspezifischer Erkrankungen des Herz-Kreislauf-Systems und der Arteriosklerose
- Aging and the Cardiovascular System
- Pulse Pressure and Diabetic Eye Disease
- Advances in the treatment of heart failure with a preserved ejection fraction
- Should pulse pressure influence prescribing?
- Arterial aging: a journey into subclinical arterial disease
- Correlates of Aortic Stiffness Progression in Patients With Type 2 Diabetes: Importance of Glycemic Control
- Novel therapies of diabetic nephropathy
- AGE-RAGE signalling in endothelial dysfunction and atherosclerosis in diabetes
- New methods of assessment of subclinical changes in the cardiovascular system in arterial hypertension
- Cardiovascular aging: the next frontier in cardiovascular prevention
- Vascular Biology of the metabolic syndrome
- 28 Diabetes, lipids and other cardiovascular risk factors
- Diabetes, pulse pressure and cardiovascular mortality: the Hoorn Study
- Hypertension management for the primary care clinician
- Cardiovascular changes with aging
- The pathogenesis of arterial stiffness and its prognostic value in essential hypertension and cardiovascular diseases
- The year in hypertension
- Impact of diabetes and hypertension on the heart
- Ventricular–vascular coupling in hypertension: methodological considerations and clinical implications
- Phlorizin exerts direct protective effects on palmitic acid (PA)-induced endothelial dysfunction by activating the PI3K/AKT/eNOS signaling pathway and …
- Cardiomyopathy and heart failure in aging
- Some mechanical aspects of arterial aging: physiological overview based on pulse wave analysis
- DISRUPTIONS OF ELASTIC ARTERIES PROPERTIES AND ENDOTHELIAL FUNCTION: MODERN METHODS FOR CORRECTION AND PREVENTION
- The Effect of Vitamin D3 Supplementation on Advanced Glycation End Products,(AGEs) And Soluble Receptor,(sRAGE) in African Americans and Hispanics with Type …
- Aging of the heart and arteries: relevance to cardiovascular disease
- Translational potential of high-resistance inspiratory muscle strength training
- Escape velocity: why the prospect of extreme human life extension matters now
- Systolic hypertension in the elderly: arterial wall mechanical properties and the renin–angiotensin–aldosterone system
- MANAGEMENT OF HYPERTENSION: NEW PERSPECTIVES
- Assessment of total cardiovascular risk in hypertensive subjects
- An analysis of the determinants of peripheral conduit arterial stiffness in children and teenagers in health and disease
- Glycosylation Inhibitors, PKC Inhibitors and Related Interventions Against Complications
- Role of the augmentation index in hypertension
- Arterial stiffness and the systolic hypertension syndrome
- Vascular aging: from molecular to clinical cardiology
- Diabetes and Advanced Glycoxidation End-Products
- Non-invasive measurements of arterial function: What? When? Why should we use them?
- Repurposing alagebrium for diabetic foot ulcer healing: Impact on AGEs/NFκB/NOX1 signaling
- Advanced glycation end products impair coronary artery BK channels via AMPK/Akt/FBXO32 signaling pathway
- Evidence that methylglyoxal and receptor for advanced glycation end products are implicated in bladder dysfunction of obese diabetic ob/ob mice
- Phyllanthus emblica L. extract alleviates leptin resistance and lipid accumulation by inhibiting methylglyoxal production
- RAGE signaling regulates the progression of diabetic complications
- Oxidative Stress in Health and Disease
- Advanced glycation end products: Key mediator and therapeutic target of cardiovascular complications in diabetes
- Effects of Zofenopril on Arterial Stiffness in Hypertension Patients
- The Role of Advanced Glycation End-Product Levels Measured by Skin Autofluorescence in the Development of Mitral Annular Calcification
- Effects of ALT-711 treatment on age-related cerebrovascular dysfunction and cognitive impairment in aged mice
- Obesity does not alter vascular function and handgrip exercise hemodynamics in middle-aged patients with hypertension
- Receptor for advanced glycation end‐products: Biological significance and imaging applications
- Receptors for Advanced Glycation End Products (RAGE): promising targets aiming at the treatment of neurodegenerative conditions
- Current understanding of structural and molecular changes in diabetic cardiomyopathy
- A Perspective on the Impact of Advanced Glycation End Products in the Progression of Diabetic Nephropathy
- Effects of aging and endurance exercise training on cardiorespiratory fitness and cardiac structure and function in healthy midlife and older women
- Emerging Therapy for Diabetic Cardiomyopathy: From Molecular Mechanism to Clinical Practice
- The vascular disease of diabetic kidney disease
- Glycation of LDL: AGEs, impact on lipoprotein function, and involvement in atherosclerosis
- Accumulation of advanced glycation end products in skin and increased vascular ageing in the general population: the Malmö Offspring Study
- Fluid-Structure Interactions of Peripheral Arteries Using a Coupled in silico and in vitro Approach
- Arterial Stiffness is Associated with False-Positive ST-Segment Depression in Supine Bicycle Exercise Stress Echocardiography
- Non-apoptotic programmed cell deaths in diabetic pulmonary dysfunction: the new side of advanced glycation end products
- Functioning and mechanisms of PTMs in renal diseases
- Cerebrovascular CO2 reactivity and dynamic cerebral autoregulation through the eighth decade of life and their implications for cognitive decline
- The effect of aerobic exercises on arterial stiffness in older people: A systematic review and meta-analysis
- Training the Vessels: Molecular and Clinical Effects of Exercise on Vascular Health—A Narrative Review
- A decade of aging in healthy older adults: longitudinal findings on cerebrovascular and cognitive health
- Estimation of central blood pressure waveform from femoral blood pressure waveform by blind sources separation
- Pathomechanisms of Diabetic Kidney Disease
- Effects of regular aerobic exercise on vascular function in overweight or obese older adults: A systematic review and meta-analysis
- Pathophysiology of NPH
